Training Example: ATEC Spine – Review the Data, Give Your Score & Compare to the Real AI Evaluation

[H2]
Our Business is in the Operating Room

ATEC Spine is committed to Revolutionizing the Approach to Spine Surgery.

About Us

[H1]
Valence®: Purpose-built for spine surgery

Valence unifies navigation and robotics into a seamless platform designed to advance ATEC’s procedures. Featuring a surgeon-controlled in-field camera, intentionally designed software, and a comprehensive suite of navigated instruments, Valence delivers clarity and control at every step of the procedure.
VISIT PRODUCT PAGE

[H2]
ATEC Spine Approach Technologies™

[IMG: x-ray of acdf spinal procedure]

[H2]
ACDF

Anterior Cervical Discectomy and Fusion

[IMG: x-ray of tlif procedure]

[H2]
TLIF

Transforaminal Lumbar Interbody Fusion

[IMG: ALIF Standalone procedure x-ray]

[H2]
ALIF

Anterior Lumbar Interbody Fusion

[IMG: x-ray of the pcf procedure]

[H2]
PCF

Posterior Cervical Fusion

[IMG: atec spine x-ray of the ptp procedure]

[H2]
PTP™

Prone Transpsoas

[IMG: x-ray of posterior fixation]

[H2]
PF

Posterior Fixation

[IMG: atec spine x-ray of lif procedure of the spine]

[H2]
LTP™

Lateral Transpsoas

[IMG: x-ray of plif procedure of the spine]

[H2]
PLIF

Posterior Lumbar Interbody Fusion

[IMG: Untitled (44)]

[H2]
CORPECTOMY

[H2]
ATEC Spine Latest News

[IMG: ATEC_Q1 26 Social Post_043026]

[H3]
ATEC Reports First Quarter Financial Results

May 5, 2026
Surgical revenue grew 17%; total revenue grew 14%
Net new surgeon users increased 23% year over year, reinforcing durable growth
Adjusted EBITDA of $21 million, or 11% of revenue, expanded 460 basis points year over year
Company announces refinancing of existing debt with inaugural bank facility, reducing interest expense by more than $6 million annually and extending maturities to 2031

VIEW PRESS RELEASE

[IMG: LinkedIn Newsletter_Website_March]

[H3]
March Society Meeting Highlights

April 3, 2026
March was defined by continued momentum in surgeon education and collaboration, with ATEC participating in key society meetings and regional symposia across the country. Each event provided an opportunity to engage with surgeons, share procedural insights, and highlight innovations designed to support better surgical decision-making and patient outcomes.

VIEW FULL ARTICLE

[IMG: LinkedIn Newsletter_Website_Feb]

[H3]
February Society Meeting Highlights

March 9, 2026
February reflected the global momentum behind surgeon-driven education and data-informed spine care. From deformity-focused collaboration in Asia Pacific to high-level cranial and spine discussions at Winter Clinics and innovation in lateral surgery at Spine Summit, each meeting reinforced a shared priority: advancing precision through planning, technology integration, and procedural discipline.

VIEW FULL ARTICLE

[H2]
OUR MISSION

Revolutionizing the Approach to Spine Surgery

Our Leadership

ATEC is more than a medical technology company. We are an Organic Innovation Machine™ that is focused on Revolutionizing the Approach to Spine Surgery. We are committed to creating clinical distinction by developing new approaches to treat the various pathologies to ultimately achieve the goals of spine surgery. Our ultimate vision is to become The Standard-Bearer in Spine.

[H2] stand·ard-bear·er
/ˈstandərd ˌberər/
A leading figure in a cause or movement.

ATEC is committed to delivering improved patient care, and our strengths are derived through our ability to embody our Core Values.

[H3]
Mission

Revolutionizing the Approach to Spine Surgery

[H3]
Vision

The Standard-Bearer in Spine

[H3]
Values

- Deliver high performance- Demonstrate GRIT- Be constantly curious- Commit to clinical distinction- Be gracious, familial, & inspire others- Love what you do- #ATECPROUD

[IMG: Dr. Pimenta]

[H3]
Profound Curiosity
ATEC is focused on developing new standards for spine surgery regardless of surgical approach. With so much variation in spine surgery today, there is a great opportunity for ATEC to deliver new approaches that achieve the goals of surgery –decompression, stabilization, and alignment. Luiz Pimenta MD, PhDChief Medical Officer

[H3]
A Message from Our Leadership

[H2]
Leadership

[H3]
Executive Team

[IMG: Pat Miles]

[H3]
Patrick S. Miles

Chairman and Chief Executive Officer

[H3] PATRICK S. MILES
Chairman and Chief Executive Officer
Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopaedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

[IMG: Craig Hunsacker]

[H3]
Craig Hunsaker

Executive Vice President, People & Culture

[H3] CRAIG HUNSAKER
Executive Vice President, People & Culture
Craig Hunsaker has served as Executive Vice President, People & Culture since September 2016. In this role, he is responsible for all aspects of employee recruitment, development, engagement and corporate culture. Craig also served as the Company’s General Counsel & Corporate Secretary from March 2017 to July 2023.  Craig's professional career includes 16 years practicing law at some of the world's largest technology focused law firms, advising and defending companies and management with respect to their people and trade secrets decisions, while holding various leadership positions. Craig left full-time legal practice in 2009, when he joined NuVasive, Inc., a publicly traded spinal implant company, first to serve as Vice President, Legal Affairs, then as Senior Vice President, Global Human Resources until March 2014.  From April 2014 until he joined ATEC, Craig owned a consulting business, assisting employers in the areas of Employment Law and Human Resources, including as Senior Advisor, Human Resources at General Atomics, a San Diego-based defense contractor. Craig received his J.D. from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar, and his B.S. in International Business & Finance from Brigham Young University.

[IMG: Todd-Koning-Headshot-copy]

[H3]
Todd Koning

Chief Financial Officer

[H3] TODD KONING
Chief Financial Officer
Todd Koning has served as Executive Vice President and Chief Financial Officer since April 2021. He brings over 20 years of focused medical device finance, accounting, and international experience. His ATEC appointment follows three years with Masimo Corporation, where he most recently served as Senior Vice President of Finance and Chief Accounting Officer, responsible for corporate planning and analysis, global accounting, SEC reporting, financial systems, and investor outreach. Prior to his role at Masimo, Todd served as Vice President of Finance at NuVasive, Inc. and Vice President of Finance at Ellipse Technologies, Inc., which was acquired by NuVasive in 2016. He also held various domestic and international finance and accounting leadership roles at Boston Scientific Corporation and Guidant Corporation. Todd holds an M.B.A. from Purdue University and a B.S. in Engineering from Michigan State University.

[IMG: scott-lish_new_web]

[H3]
SCOTT LISH

Chief Operating Officer

[H3] Scott Lish
Chief Operating Officer
Scott Lish has served as Chief Operating Officer since January 2024. Mr. Lish began his career at ATEC in October 2017 as Vice President, Research and Development and was promoted to Senior Vice President, Research and Development in October 2020. Prior to joining NuVasive, Mr. Lish worked for 2 years as a Manufacturing Engineer for Zimmer Dental. Mr. Lish received an M.S. degree in Material Science and a B.E. degree in Mechanical Engineering from the Thayer School of Engineering at Dartmouth, as well as a B.A. degree in Engineering Sciences from Dartmouth College.

[IMG: MicrosoftTeams-image-99]

[H3]
Tyson Marshall

General Counsel & Corporate Secretary

[H3] Tyson Marshall
General Counsel & Corporate Secretary
Tyson Marshall has served as General Counsel & Corporate Secretary since July 2023. Mr. Marshall began his career with ATEC in 2017, first as Director of Legal Affairs (2017-2018) and then as Vice President, Associate General Counsel (2018-2023). Prior to joining ATEC, Mr. Marshall served as General Counsel & Corporate Secretary (2016-2017) and Associate General Counsel (2013-2016) of Mad Catz Interactive, Inc., a global provider of innovative interactive entertainment products. Prior to moving in-house, Mr. Marshall spent over ten years in private legal practice, including eight years with the international, full-service law firm Morrison & Foerster as a member of that firm’s Securities Litigation Enforcement and White Collar Defense group. Before joining Morrison & Foerster, Mr. Marshall was a securities and IP litigator at Fish & Richardson, an IP and commercial litigation firm. Mr. Marshall earned his law degree, magna cum laude, from the University of San Diego School of Law and his B.S. in Psychology from Brigham Young University.

[IMG: David Sponsel]

[H3]
Dave Sponsel

Executive Vice President, Sales

[H3] DAVE SPONSEL
Executive Vice President, Sales
Dave Sponsel has served as Executive Vice President, Sales since April 2019. Dave began his career at Alphatec Spine as Area Vice President, Sales, South in May 2018. Prior to joining Alphatec Spine, he held the position of General Manager, Spine Division for Medacta, USA, where he was responsible for sales, marketing, product management and product development. Prior to that, he had an exceedingly successful 11-year experience in sales and sales leadership with Stryker Spine, where he was recognized as Sales Director of the Year in 2014. Dave received a BS from Indiana State University in Business Management.

[IMG: Ali Shorooghi Senior Vice President, Marketing]

[H3]
Ali Shorooghi

Senior Vice President,Marketing

[H3] Ali Shorooghi
Senior Vice President, Marketing
Ali Shorooghi has served as Senior Vice President, Marketing since November 2022. Throughout his tenure at ATEC, which commenced in 2017, Ali has served in marketing leadership roles, most recently as Vice President, Thoracolumbar Marketing. Prior to joining ATEC, Ali served on the founding team of Casetabs Inc., a cloud-based surgery coordination application that was acquired by Bain Capital. Ali joined Casetabs following a 7-year tenure at NuVasive, Inc., where he attained Marketing and Product Management roles that increased in responsibility. Ali received a Bachelor of Science in Industrial & Systems Engineering with an emphasis on Information & Operations Management from the University of Southern California.

[IMG: Joe Walland]

[H3]
Joseph Walland

Senior Vice President,Imaging Solutions

[H3] Joseph Walland
Senior Vice President, Imaging Solutions
Joseph Walland has served as Senior Vice President, Imaging Solutions since January 2022, having previously held the position of Vice President, Sales Channel Development since December 2020. Prior to joining ATEC, Mr. Walland held the position of U.S. Chief Executive Officer at Medicrea, a full-service spinal technology company focused on data-driven surgical planning and personalized implant offerings, where he led the sale of that company to Medtronic in November 2020. For the thirteen years prior to joining Medicrea, Mr. Walland held various sales and marketing leadership positions at Stryker Spine from 2004 to 2017. He most recently held the position of Area Vice President of Sales-West, where he was responsible for the development and growth of the sales channel for the western half of the U.S. Mr. Walland received a B.A. degree in History from Yale University.

[H3]
Board of Directors

The Board of Directors has direct access to independent experts – lawyers, accountants and compensation experts – to turn to for counsel regarding specific company polices and activities.
The Audit Committee of the Board of Directors pre-approves all audit and permitted non-audited services, and reviews quarterly and year-end financial statements and associated press releases with our financial management and outside, independent auditors in advance of the filing or release of such documents.
The Compensation Committee of the Board of Directors approves all compensation-related matters involving Alphatec Spine’s senior management. In addition, The Compensation Committee of the Board of Directors approves all bonus plans and acts as the administrator of the company’s stock option plan and employee stock purchase plan.

[IMG: Pat Miles]

[H3]
Patrick S. Miles

Chairman and Chief Executive Officer

[H3] PATRICK S. MILES
Chairman and Chief Executive Officer
Patrick S. Miles has served as Chairman and Chief Executive Officer of Alphatec Holdings and Alphatec Spine since October 2017. Mr. Miles has over 20 years of experience in the orthopaedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive. As Vice Chairman, Mr. Miles was responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles served as a member of NuVasive’s Board of Directors since August 2016 until his resignation in September 2017. Prior to that, Mr. Miles served as NuVasive’s President and Chief Operating Officer from February 2015 to September 2016. He previously served as NuVasive’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

[IMG: Mortimer Berkowitz III]

[H3]
Mortimer Berkowitz III

Lead Director, Chairman of the Nominating and Corporate Governance Committee, Member of the Audit Committee, Member of the Compensation Committee

[H3] MORTIMER BERKOWITZ III
Lead Director, Chairman of the Nominating and Corporate Governance Committee
Mortimer Berkowitz III is the Lead Director and has served as a member of the Board of Directors since March 2005. From April 2007 through July 2011, he also served as the Chairman of the Board of Directors. He is currently President and CEO of InnovaHealth Partners, L.P. He is also a managing member of HGP, LLC, which is the general partner of HealthpointCapital Partners, LP, President, and a managing director of HealthpointCapital, LLC. He has held the position with HGP, LLC since its formation in August 2002, as well as the positions of managing director and member of the Board of Managers of HealthpointCapital, LLC since its formation in July 2002 and the position of President of HealthpointCapital, LLC since February 2005. Prior to joining HealthpointCapital, LLC, Mr. Berkowitz was managing director and co-founder of BPI Capital Partners, LLC, a private equity firm founded in 1990. Prior to 1990, Mr. Berkowitz spent 11 years in the investment banking industry with Goldman, Sachs & Co., Lehman Brothers Incorporated and Merrill Lynch & Co. Mr. Berkowitz serves on the Leadership Council of the Harvard School of Public Health.

[IMG: Quentin Blackford]

[H3]
Quentin Blackford

Director, Member of the Audit and Compensation Committees

[H3] QUENTIN BLACKFORD
Director, Member of the Audit and Compensation Committees
Quentin Blackford has served as a Director since October 2017. He currently serves as the Chief Executive Officer of iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of c

[IMG: Spineman_LIF2]

[H2]
PTP™

Prone Transpsoas

Next Approach

[H2]
Procedural Offerings

[IMG: LAT_ID2 LIF_flipped]

[IMG: Valence Cart Transparent]

[H4] Navigation & Robotics

Valence®

[IMG: Untitled-5 (4)]

[H4] Informatix™

Arcus™ Guided Access System
SafeOp®
ATEC Insight™

[IMG: PTP Retractor_Hero]

[H4] Access

Sigma™ LIF-PTP Access System

[IMG: PTP Positioners_On Rail2]

[H4] Patient Positioner

PTP™ Patient Positioner

[IMG: IDII Implant_Oblique_nose_2]

[H4] Interbody Implants

IdentiTi™ II LIF
Calibrate™ LTX
IdentiTi™ LIF
Transcend™ LIF

[IMG: LIF_AMP Angle]

[H4] Anti-Migration

AMP™ II (Anti-Migration Plate)
AMP™ (Anti-Migration Plate)
AMP™ LTX

[IMG: Biologics materials for spine surgery]

[H4] Biologics

AlphaGRAFT® DBM Fiber and Fiber Strip

[IMG: ACDF_Spineman]

[H2]
ACDF

Anterior Cervical Discectomy
and Fusion

Next Approach

[H2]
Procedural Offerings

[IMG: Cervical_web_fluoro1]

[IMG: Untitled-5 (4)]

[H4] INFORMATIX™

SafeOp®
ATEC Insight™

[IMG: ACDF_IdentiTI-C SA Hero]

[H4] Interbody Implants

IdentiTi™-C Standalone
IdentiTi™ -C
Cervical Structural Allografts
Novel® CIS

[IMG: Insignia 2 Level Plate]

[H4] Fixation

Insignia™
Trestle Luxe™ II

[IMG: Biologics materials for spine surgery]

[H4] Biologics

AlphaGRAFT® DBM Fiber and Fiber Strip
AmnioShield®